FDA Drug Application (022299) for NEVIRAPINE TABLETS FOR ORAL SUSPENSION by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number022299
Product Number001
FormTABLET; ORAL
Dosage50MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEVIRAPINE TABLETS FOR ORAL SUSPENSION
Active IngredientNEVIRAPINE

Active IngredientCount
List of drugs with Active Ingredient NEVIRAPINE17


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD